1-(5-isoquinolinesulfonyl)-2-methylpiperazine has been researched along with cefoxitin in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hayashi, M; Kaiho, F; Shibasaki, T; Takahashi, H; Takeshita, K | 1 |
1 other study(ies) available for 1-(5-isoquinolinesulfonyl)-2-methylpiperazine and cefoxitin
| Article | Year |
|---|---|
The enhancing mechanism of capric acid (C10) from a suppository on rectal drug absorption through a paracellular pathway.
Topics: 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine; Administration, Rectal; Animals; Cefoxitin; Cephamycins; Decanoic Acids; Intestinal Absorption; Male; Myosin-Light-Chain Kinase; Protein Kinase C; Rats; Rats, Wistar; Rectum; Sulfonamides; Suppositories | 1997 |